A comparative study of the inhibitory effect of Atabrine on R-and R+ strains of Escherichia coli showed that R+ cells were killed when grown in the presence of Atabrine, whereas R-cells were not. It would appear, therefore, that R factor confers sensitivity to Atabrine on the host cells. The "curing" of R factor from R+ cells by the ultraviolet light-acridine orange method rendered the "cured" cells more resistant than even the parent R-cells. The "cured" cells reinfected by R factor were more sensitive than the "cured" cells but less sensitive than the original R+ cells. After growth once in Atabrine, and even after subcultures in drug-free medium, the (8, 24, 26) . In addition, it has been reported that deoxycholate derivatives (12, 13), mitomycin C (27), sodium dodecylsulfate (27), fatty acids (10), surfaceactive detergents (K. Kato, personal communication), acridine derivatives (9), and trimethylamine derivatives (9) prevent the transfer of R factor, mainly in vitro and in some cases in vivo. Acridine orange and acriflavine have been shown to be capable of "curing" R factor, in vitro. Despite all of these studies, there is still no clni-1 On leave of absence from Department of Microbiology, School of Medicine, University of Tokyo, Tokyo, Japan. cally effective means either to prevent the spread of R factor or to "cure" it effectively from bacteria. Furthermore, the recent reports showing the emergence of new types of R factors possessing resistance to kanamycin (11, 14, 27; Y. Terawaki, personal communication), neomycin (26), and penicillin derivatives (4, 5) portend the possibility of the emergence of new types of R factor possessing transferable resistance to newly discovered antibiotics. Recently, it has been found that over 65 % of dysentery bacilli isolated in some districts of Japan possess R factor (T. Akiba, personal communication).
and R+ cells were grown in 120 ,ug/ml of Atabrine, R+ cells were killed and the culture consisted predominantly of R-cells. A mixture of R-and R+ cells (1:10,000) inoculated into the Atabrine-containing medium and treated 24 hr later with chloramphenicol was completely killed.
Akiba et al. (2, 3) and Ochiai et al. (19) discovered that multiple drug resistance to sulfonamides, streptomycin (SM), chloramphenicol (CM) , and tetracycline in Enterobacteriaceae is transferable (or infective) to drug-sensitive strains by in vitro mixed cultivation. Numerous later studies, especially in the field of microbial genetics, have reported on this phenomenon and its genetic determinant, the R factor. The R factor has been found to possess the ability to confer maleness on Escherichia coli K-12 (22) and to interfere with F mating (18, 24, 25, 29, 30) , F infection (24, 25) , phage growth (26, 31) , and superinfection by R factor (8, 24, 26) . In addition, it has been reported that deoxycholate derivatives (12, 13) , mitomycin C (27) , sodium dodecylsulfate (27) , fatty acids (10) , surfaceactive detergents (K. Kato, personal communication), acridine derivatives (9) , and trimethylamine derivatives (9) prevent the transfer of R factor, mainly in vitro and in some cases in vivo. Acridine orange and acriflavine have been shown to be capable of "curing" R factor, in vitro. Despite all of these studies, there is still no clni-1 On leave of absence from Department of Microbiology, School of Medicine, University of Tokyo, Tokyo, Japan. cally effective means either to prevent the spread of R factor or to "cure" it effectively from bacteria. Furthermore, the recent reports showing the emergence of new types of R factors possessing resistance to kanamycin (11, 14, 27 ; Y.
Terawaki, personal communication), neomycin (26) , and penicillin derivatives (4, 5) portend the possibility of the emergence of new types of R factor possessing transferable resistance to newly discovered antibiotics. Recently, it has been found that over 65 % of dysentery bacilli isolated in some districts of Japan possess R factor (T. Akiba, personal communication).
We have studied the effect of Atabrine on R+ bacteria and have found that cells carrying R factor are more sensitive to Atabrine than the original uninfected cells; in other words, the infection by R factor conferred "sensitivity to Atabrine" on the bacterial hosts. In the present report, the general features of this phenomenon and its possible bearing on clinical use will be presented. Genetic and biochemical studies will be presented in subsequent publications. Fig. 1 and 2A) . Turbidimetric observation showed a greater degree of growth inhibition by Atabrine of R+ than of R-cells until about 30 hr, after which time the R+ culture showed a more rapid increase in turbidity than did the R-one. In the presence of Atabrine, the viable counts of the R-cells remained almost constant during the initial 25 hr, and then gradually increased; the counts of R+ cells decreased steadily to about 10 to 20% of the inoculum size at 10 hr, followed by a rapid increase which reached a higher viable count than that of the R- Atabrine sensitivity in order to eliminate the possibility that the sensitivity previously described was strain-specific. The R+ cells of all three sets tested were more sensitive to Atabrine than were their counterpart R-cells (Fig. 2) .
Effect of prior exposure to Atabrine on the growth inhibitory effect on R-and R+ cells. After the growth of R-and R+ cells in Atabrine had reached the stage when the number of R+ cells was greater than that of R-cells (44 hr), 0.05-mi samples from each system were transferred to 5 ml of SGCH and incubated. After two additional subcultures in SGCH, these cells were used as the inoculum for the same systems as previously used for the unexposed cells. Atabrine-exposed R+ cells showed a higher growth rate in the presence of Atabrine than did R-cells which had received the same treatment (Table 3) .
Inhibitory effect of Atabrine on the growth of R-cells derived by "curing" the R factor from R+ cells. If the sensitivity to Atabrine of R+ cells is attributable to the existence of R factor itself, the R-strain obtained by "curing" the R factor from R+ cells should show the same sensitivity as the original R-cells. An R-strain, YC-74, obtained by "curing" the R factor from YC-73 (R203+) by treatment with acridine orange after irradiation with UV light, was tested for Atabrine sensitivity. The sensitivity of YC-73 did in fact disappear by the "curing" procedure, but, instead of returning to the original sensitivity of R-cells, strain YC-74 grew at a greater rate in the presence of Atabrine than did the original R-strain (Table 4) . These data suggest the possibility of cross-resistance between acridine orange and Atabrine, owing to their structural similarity. Since the effect of (Table 6 ). Atabrine alone, or combined with CM at zero-time, resulted in an initial decrease in viable cells at 24 hr, followed finally by growth. In contrast, the addition of CM to systems containing Atabrine after 24, 48, or 72 hr of incubation was lethal for the cells. Similar experiments with 120 ,ug/ml of Atabrine gave similar results, but sometimes a small number of R+ cells survived. DIsCUSSION In this report, it has been shown that R+ strains of E. coli are more sensitive to Atabrine than the original R-strains, and that it is R factor itself which appears to be responsible for this sensitivity. This conclusion is supported by the fact that the R-cells obtained by "curing" by the UVacridine orange method showed a greater degree of resistance than the original R+ cells and that R+ cells obtained by reinfection of the "cured" cells showed a greater degree of sensitivity than the "cured" R-cells. The additional finding that the "cured" R-cells were less sensitive to Atabrine than were the original R-cells, and that analogously the R+ cells obtained from the "cured" R-cells by the reinfection of R factor were less sensitive to Atabrine than were the original R+ cells, may be related to a cross-resistance arising from the structural similarity between acridine orange and Atabrine.
Further study showed that, during the first contact with Atabrine, the initial sensitivity of the R+ cells was followed by a growth rate faster than that of the R-cells. Subculture of these cells, both R+ and R-, in medium free from Atabrine, followed by growth in the presence of Atabrine, revealed a greater resistance of the Atabrine-exposed R+ cells than that of the Atabrine- R factor possessing the ability to confer a higher degree of mutability may come from future investigations. Ginoa and Painter (7) reported that a strain of E. coli carrying R factor with SM, CM, and sulfonamide resistance markers gave rise to a higher mutability to SM and CM resistance than did its original R-strain. Although, in their case, the R+ cells were originally carrying the SM and CM resistance markers on their R factor, the newly acquired higher-resistance markers were located on the chromosome of the host cell. In our case, however, it is not known at this time where the newly acquired Atabrine resistance is located in Atabrine-exposed R+ cells. Although several different strains of R+ cells were found to show greater sensitivity to Atabrine than did the original R-cells, at least more than one R factor failed to confer sensitivity to Atabrine on the bacterial hosts. The "linkage" relationship among various genetic characteristics which have been studied previously and the characteristic "sensitivity to Atabrine" will be reported later.
The results (Table 5 ) of experiments with mixed cultures of R+ and R-cells may be of clinical significance. In those systems containing Atabrine alone, there was a marked change in the population producing a predominance of R-cells, even when the population mixture initially consisted of 1 R-cell per 1 million R+ cells. This shift may be attributed to the selective killing of R+ cells, while R-cells were able to multiply in the presence of Atabrine. The results (Table 6 ) with CM addition, after preincubation of mixed populatioms of R+ and R-cells in the presence of Atabrine, may also be due to the overgrowth of the R-cells which in turn would be sensitive to the action of CM.
Akiba (1) cited several cases of simultaneous or successive isolation of both R-and R+ dysentery bacilli of the same serological types from the same patient. In these clinical and epidemiological studies, the number of colonies taken from each patient and tested for drug resistance was very small. Even under such conditions of limited detectability, coexistence of R-and R+ cells in the same patient was shown. On the other hand, during the in vitro studies on R factor, the segregation of R-cells in R+ cultures have often been encountered.
On the basis of these findings, one may suppose that an intestinal flora composed mainly of R+ cells with few R-cells would yield predominantly R-cells after the administration of Atabrine. Under such conditions, these cells could be expected to be killed effectively by the successive administration of antibiotics. In view of the results reported previously from our laboratory (20, 21) , combined with the effective killing by a combination of Atabrine and CM demonstrated in this report, the treatment with Atabrine followed by a combination of Atabrine and antibiotics might be the most effective means of dealing with such infections.
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